Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

[A case of recurrent breast cancer with multiple bone metastasis successfully treated with S-1 and zoledronic acid therapy].

Murata T, Yoshino H, Kaneko M, Yamada T.

Gan To Kagaku Ryoho. 2013 Feb;40(2):229-31. Japanese.

PMID:
23411961
2.

[A successful case treated with S-1 and zoledronic acid for multiple bone metastasis of breast cancer].

Nakamoto Y, Kayata Y, Kikawa Y, Ogata M, Yamamoto M.

Gan To Kagaku Ryoho. 2011 May;38(5):811-3. Japanese.

PMID:
21566443
3.

[A case of multi-drug resistant recurrent breast cancer with multiple bone metastasis responding to TS-1 and trastuzumab].

Nakajima H, Mizuta N, Mizuta M, Nakatsukasa K, Kobayashi A, Hachimine Y, Sakaguchi K, Fujiwara I, Sawai K.

Gan To Kagaku Ryoho. 2006 Sep;33(9):1305-8. Japanese.

PMID:
16969030
4.

[A case of recurrent breast carcinoma metastasis successfully treated with S-1 and zoledronic acid therapy].

Tanaka Y, Kurokawa T, Arita K, Kuramochi J, Usui S, Matsumoto A, Takiguchi N, Hiranuma S, Sanada K.

Gan To Kagaku Ryoho. 2009 Jan;36(1):97-9. Japanese.

PMID:
19151571
5.

Effect of zoledronic acid on the doxycycline-induced decrease in tumour burden in a bone metastasis model of human breast cancer.

Duivenvoorden WC, Vukmirović-Popović S, Kalina M, Seidlitz E, Singh G.

Br J Cancer. 2007 May 21;96(10):1526-31. Epub 2007 Apr 17.

6.

Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone.

Ottewell PD, Woodward JK, Lefley DV, Evans CA, Coleman RE, Holen I.

Mol Cancer Ther. 2009 Oct;8(10):2821-32. doi: 10.1158/1535-7163.MCT-09-0462. Epub 2009 Sep 29.

7.
8.

The role of zoledronic acid in the adjuvant treatment of breast cancer: current perspectives.

Tonyali O, Arslan C, Altundag K.

Expert Opin Pharmacother. 2010 Nov;11(16):2715-25. doi: 10.1517/14656566.2010.523699. Review.

PMID:
20977404
9.

Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases.

Ibrahim A, Scher N, Williams G, Sridhara R, Li N, Chen G, Leighton J, Booth B, Gobburu JV, Rahman A, Hsieh Y, Wood R, Vause D, Pazdur R.

Clin Cancer Res. 2003 Jul;9(7):2394-9.

10.

[A case of possible retroperitoneal metastasis of breast cancer successfully treated with oral S-1 and cyclophosphamide therapy after TC therapy].

Yoneyama K, Takeshita T, Suzuki H, Morise M, Suzuki T, Kishi S, Tsutsui A, Matsumoto A.

Gan To Kagaku Ryoho. 2011 Mar;38(3):435-7. Japanese.

PMID:
21403449
11.

[A case of repeated bone metastases of breast carcinoma successfully treated by S-1 chemotherapy].

Takeyama H, Kyoda S, Yamashita A, Kinoshita S, Okamoto T, Uchida K, Morikawa T.

Gan To Kagaku Ryoho. 2011 Nov;38(11):1873-5. Japanese.

PMID:
22083201
12.

[Long-term complete response in a patient with breast cancer and bone and pleura metastases after treatment with a combination of S-1 and zoledronic acid].

Mizuta N, Sakaguchi K, Mizuta M, Ichida M, Ohashi M, Umeda Y, Nishiyama A, Matsumoto M, Fujiwara I.

Gan To Kagaku Ryoho. 2010 Jul;37(7):1317-20. Japanese.

PMID:
20647717
13.

[A case of gastric cancer with multiple bone metastasis that responded to S-1 with low-dose cis-platinum].

Maruyama S, Iga N, Shimo T, Masuda H, Tomii K, Shoga K, Kanaya Y, Yokoyama N.

Gan To Kagaku Ryoho. 2008 Jan;35(1):125-7. Japanese.

PMID:
18195541
14.

[Efficacy of zoledronic acid combined with chemotherapy in treatment of skeletal metastases of non-small cell lung cancer and the bone metabolic markers].

Hu XY, Zou QF, Jin C, Li WD, Chen WS, Ma L.

Nan Fang Yi Ke Da Xue Xue Bao. 2010 Jun;30(6):1343-6. Chinese.

15.

Bisphosphonates and metastatic breast carcinoma.

Lipton A.

Cancer. 2003 Feb 1;97(3 Suppl):848-53. Review.

16.

Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo.

Ottewell PD, Deux B, Mönkkönen H, Cross S, Coleman RE, Clezardin P, Holen I.

Clin Cancer Res. 2008 Jul 15;14(14):4658-66. doi: 10.1158/1078-0432.CCR-07-1545.

17.

Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial.

Rosen LS, Gordon D, Kaminski M, Howell A, Belch A, Mackey J, Apffelstaedt J, Hussein M, Coleman RE, Reitsma DJ, Seaman JJ, Chen BL, Ambros Y.

Cancer J. 2001 Sep-Oct;7(5):377-87.

PMID:
11693896
18.

[A case of multiple metastases breast cancer controlled using S-1 as third-line chemotherapy].

Nakajima F, Matsuoka K, Ogawa T, Nomura H, Araya J.

Gan To Kagaku Ryoho. 2011 Jul;38(7):1163-5. Japanese.

PMID:
21772103
19.

Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases.

Berenson JR, Rosen LS, Howell A, Porter L, Coleman RE, Morley W, Dreicer R, Kuross SA, Lipton A, Seaman JJ.

Cancer. 2001 Apr 1;91(7):1191-200. Erratum in: Cancer 2001 May 15;91(10):1956.

PMID:
11283917
20.

[A case of advanced gastric cancer treated with S-1 and S-1/paclitaxel showing complete response twice].

Matsuyama J, Naitou A, Hiraki M, Matsumoto S, Hashimoto K, Yokoyama S, Morita S, Morimoto T, Fukushima Y, Nishishou I, Nomura T, Sasaki Y.

Gan To Kagaku Ryoho. 2009 Nov;36(12):2297-9. Japanese.

PMID:
20037401

Supplemental Content

Support Center